FN1 and breast cancer: Furthermore, higher expression of EDB-FN was found to significantly correlate with poor overall survival (Figure 1B) in the breast cancer patients, with a hazard ratio of 1.9 [p(HR)=0.022], demonstrating its prognostic value.